AFS Zorgapotheek SRL

43.7 FTE

AFS Zorgapotheek reported total assets of €2.57m at the end of the 2025 financial year (annual accounts filed with the NBB on 24 Jun 2026), with 43.7 full-time equivalents.

Company number (CBE) 1007.931.354 · VAT BE1007931354
2600 Antwerp
active in Retail sale of pharmaceutical products (NACE 47730)
operating since 03 Apr 2024 (≈ 2 yrs)
Public Public page: latest year only. The score, history and details open with a free account. Create a free account
Idonis solidity score
EDCBA

The score of AFS Zorgapotheek shows with a free account.

See the score
Profile
SRL Small · 43.7 FTE since 2024
Components
  • Summary? / 5
    • Balance sheet strength
    • Liquidity
    • Repayment capacity
    • Profitability
    • Trajectory
    • Compliance and register
  • Position in its sectorvs peers
  • Supplier creditat 30 d
  • Borrowing capacityborrowable
  • Valuationcentral

Visible once signed in: create your account, the 14-day Pro trial is free.

Detail

Key figures 2025

Net result−€4.95m
Equity−908,397 €
Cash181,848 €
EBITDA−€4.25m
Total assets€2.57m
Headcount (avg FTE)43.7
Solvency-35.4%
The line marks its sector median: 44.2% (2068 companies).

Accounts of the company itself (not consolidated).

Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error

AFS Zorgapotheek's annual accounts

2025
Net result−€4.95m
Equity−908,397 €
Cash181,848 €
EBITDA−€4.25m
Total assets€2.57m

Filed annual accounts

  • Year ended 30 Dec 2025filed on 24 Jun 2026

AFS Zorgapotheek's financial analysis

Management and control of AFS Zorgapotheek

5 active director(s) in the register.

AFS Zorgapotheek's shareholders and holdings →

AFS Zorgapotheek's publications in the Belgian Gazette

Company number, VAT number and registered office

Company number (CBE)
1007.931.354
VAT number
BE1007931354
Peppol
Registered · 0208:1007931354 · as of 10 Nov 2026
Legal form
SRL
Incorporated
03 Apr 2024
Registered office
2600 Antwerp
Size
Small · 43.7 FTE
Latest accounts
2025 · filed on 24 Jun 2026
Activity
Retail sale of pharmaceutical products (NACE 47730)

AFS Zorgapotheek (SRL) has been based in Antwerp since 2024, active in: retail sale of pharmaceutical products. For 2025, it reports a net loss of €4.95m and equity of −908,397 €; its revenue is not published. With 43.7 full-time equivalents, it is a small enterprise by headcount. Its solvency stands at -35.4%, below the median of its sector (44.2%).

Guide: Reading Belgian SME accounts: the five figures that count →

Companies similar to AFS Zorgapotheek

Companies in the same business, of comparable size and area, outside its group.

Frequently asked questions about AFS Zorgapotheek

What is the revenue of AFS Zorgapotheek?

AFS Zorgapotheek files its accounts in a format where revenue is optional: it is not published for 2025.

What is the VAT number of AFS Zorgapotheek?

In Belgium, the VAT number is the company number prefixed with BE: BE1007931354 for AFS Zorgapotheek, if the company is VAT-registered. Its company number (CBE) is 1007.931.354.

Where is the registered office of AFS Zorgapotheek?

According to the CBE register, the registered office of AFS Zorgapotheek is in 2600 Antwerp.

What is the equity of AFS Zorgapotheek?

At the close of the 2025 financial year, the equity of AFS Zorgapotheek amounts to -908,397 €, a solvency of -35.4% of total assets.

How many people work at AFS Zorgapotheek?

43.7 full-time equivalents on average according to the 2025 social balance sheet.

Who manages AFS Zorgapotheek?

The register lists 5 active mandates at AFS Zorgapotheek. Names and roles are in the full file, with the deeds published in the Belgian Gazette.

Idonis

The full file of AFS Zorgapotheek

Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.

Open the full file →
Free account in 30 seconds, by email. No bank card.
Sources : Annual accounts — NBB ↗ Register — CBE ↗ Deeds — Belgian Gazette ↗ · Updated on 10 Sep 2026

No credit card, no commitment.

What each plan unlocks →